The National Institutes of Health (NIH) on Friday made a significant reduction in grants reserved for research institutions, a decision that may significantly impact American higher education.

“Without relief from NIH’s action, these institutions’ cutting-edge work to cure and treat human disease will grind to a halt.” The NIH is the primary source of federal funding for medical ...

The money supports “the research infrastructure,” said Iwashyna, who relies on NIH funding for research on chronic illnesses, including pneumonia, among the leading causes of hospitalizations ...

Tabak, a dentist and researcher, was appointed as the NIH’s principal deputy director in 2010. His tenure spans four presidential administrations, and includes a nearly two-year stint as the ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

The U.S. National Institutes of Health (NIH) is the largest funder of biomedical research in the world, and its grants create the foundation of basic science knowledge on which major health ...

Applications for a prestigious National Institutes of Health grant program that supports Ph.D. students from marginalized backgrounds are ... On Jan. 24, the NIH website suddenly showed the ...

National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...

Scientific researchers are concerned after the National Institutes of Health (NIH) abruptly canceled numerous meetings essential to the fellowship and grant approval process earlier this week.

Within hours, as word of NIH meeting cancellations pinged across the social media platform Bluesky, she realized that this wasn’t only about the opioid research she would be reviewing ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

Though Memoli is an NIH insider, one source familiar with him noted his perspectives —particularly his opposition to Covid-19 vaccine mandates — make him more of an outsider at the agency.